Biogen Inc (NASDAQ:BIIB) stock end the session low on Friday.
Market Action
BIIB stock fell over 1.15% to close at $283.19. More than 940K shares traded hands for the session, compared to its 30-day average volume of 1.08 million shares. The stock opened at $288.24 and moved within a range of $282.78 – 289.91 on Friday.
BIIB Issued News
Biogen and Ginkgo Bioworks Announce Collaboration and License Agreement to Develop Novel Gene Therapy Manufacturing Platform
- BIIB announced a gene therapy collaboration. Together, the companies aim to redefine the industry standard for manufacturing recombinant adeno-associated virus (AAV)-based vectors.
- Recombinant AAV-based vectors are widely used to develop innovative gene therapies and have the potential to treat certain neurological and neuromuscular diseases as well as other conditions across multiple therapeutic areas.
Trader Notes
Share Information
| SHARES OUTSTANDING | 150.55 M |
| SHARE FLOAT (%) | 150.27 M (99.81%) |
| % HELD BY INSTITUTIONS | 86.70 |
Recent Stock Performance
| 5-DAY PERF. | +1.06% |
| 1-MONTH PERF. | +4.94% |
| 3-MONTH PERF. | +1.74% |
| 6-MONTH PERF. | +15.99% |
| YTD PERF. | +15.65% |
| 5-DAY PERF. | +1.06% |
Moving Averages
| +/- EMA(20) | 276.94 (+2.26%) |
| +/- SMA(50) | 271.42 (+4.34%) |
| +/- SMA(200) | 268.80 (+5.35%) |
Pivot Points
| Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
| Classic | 273.5467 | 278.1633 | 280.6767 | 285.2933 | 287.8067 | 292.4233 | 294.9367 |
| Fibonacci | 278.1633 | 280.8870 | 282.5697 | 285.2933 | 288.0170 | 289.6997 | 292.4233 |
Technical Indicators
| Symbol | Value | Result | Symbol | Value | Result |
| ADX | 10.1719 | Neutral | ATR14 | 6.9738 | |
| CCI20 | 131.5321 | Buy | Chaikin Money Flow | 0.0605 | Buy |
| MACD | 3.7065 | Buy | Money Flow Index | 45.8641 | Sell |
| ROC | 4.2788 | Buy | RSI | 59.6116 | Buy |
){kind=link}